Click Here to return To Results

 

Tolrestat for Mild Diabetic Neuropathy, A 52-Week Randomized, Placebo-Controlled Trial Ann Int Med 118:7-11, Guigliano,D.,et al, 1993 See this aricle in Pubmed Article Abstract The progression of mild diabetic autonomic and peripheral neuropathy may be halted or even reversed by pharmacologic intervention with the aldose- reductase inhibitor tolrestat.

Related Tags

(click to filter results - removes previous filter) aldose reductase inhibitor autonomic dysfunction neuropathy neuropathy,diabetic neuropathy,peripheral,treatment tolrestat treatment of neurologic disorder

Click Here to return To Results